Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra and Pegsunercept Combination in Rheumatoid Arthritis
NCT00037700Phase 2Completed
- Sponsor
- Amgen
- Start
- May 2001
- Modality
- PEGylated Peptides, Fc-Fusion Proteins
01
Overview
A Phase 2 trial of pegsunercept in rheumatoid arthritis (RA), sponsored by Amgen. Started May 2001; status: completed.
02
Drugs
pegsunercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00037700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00037700.